Elhomsy, G and Griffing, G. (Updated 2012 August 31). Apolipoprotein A-I. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/2087313-overview through http://emedicine.medscape.com. Accessed March 2014.

Delgado, J. et. al. (Updated 2014 February). Cardiovascular Disease (Non-traditional Risk Markers) - Risk Markers - CVD (Non-traditional) ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/CVDRiskMarkerNontrad.html?client_ID=LTD through http://www.arupconsult.com. Accessed March 2014.

(© 1995–2014). Apolipoprotein A1, Plasma. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at http://www.mayomedicallaboratories.com/test-catalog/Overview/80309 through http://www.mayomedicallaboratories.com. Accessed March 2014.

Lam, J. (Revised 2012 September) Atherosclerosis. Merck Manual for Healthcare Professionals [On-line information]. Available online through http://www.merckmanuals.com. Accessed March 2014.

Pagana, K. D. & Pagana, T. J. (© 2011). Mosby's Diagnostic and Laboratory Test Reference 10th Edition: Mosby, Inc., Saint Louis, MO. Pp 112-115.

Clarke, W., Editor (© 2011). Contemporary Practice in Clinical Chemistry 2nd Edition: AACC Press, Washington, DC. Pp 288-289.

McPherson, R. and Pincus, M. (© 2011). Henry's Clinical Diagnosis and Management by Laboratory Methods 22nd Edition: Elsevier Saunders, Philadelphia, PA. Pp 240.

Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.

ARUP's Guide to Clinical Laboratory Testing (CLT). Apolipoprotein A-1 [On-line information]. Available online at http://www.arup-lab.com/guides/clt/tests/clt_al67.htm#1142700 through http://www.arup-lab.com.

Theoretical Biophysics Group (2001 February 19, Modified). HDL and Apo A-1 Structure Prediction. NIH Resource for Macromolecular Modeling and Bioinformatics [On-line information]. Available online at http://www.ks.uiuc.edu/Research/apoa1/ through http://www.ks.uiuc.edu.

Hargrove, G.M., Junco, A., and Wong, N.C.W. (1999). Hormonal regulation of apolipoprotein AI. Journal of Molecular Endocrinology 22, 103-111 [On-line Journal]. PDF available for download at http://journals.endocrinology.org/jme/022/0103/0220103.pdf through http://journals.endocrinology.org.

(2000 March). What Are Cholesterol, Other Lipids, And Lipoproteins? Northern Berkshire Health Systems, Health A to Z [Well-Connected Online report]. Available online at http://www.nbhealth.org/myhealthadviser/atoz/doc23.html through http://www.nbhealth.org.

Pagana, Kathleen D. & Pagana, Timothy J. (© 2007). Mosby's Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO., Pp 110-114.

Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry, AACC Press, Washington, DC. Winter, W. and Harris, N. Chapter 21: Lipoprotein Disorders, Pp 251-259.

O'Riordan, M. (2007 March 22). High Levels of Apolipoprotein A1 and HDL Associated With Reduced Risk of Recurrent VTE. Heartwire - a professional news service of WebMD [On-line information]. Available online at http://www.medscape.com/viewarticle/554016 through http://www.medscape.com.

Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds, (2005). Harrison's Principles of Internal Medicine, 16th Edition, McGraw Hill.

Benderly, M. et. al. (2009 February 16). Apolipoproteins and Long-Term Prognosis in Coronary Heart Disease Patients. Medscape from American Heart Journal. 2009;157(1):103-110 [On-line information]. Available online at http://www.medscape.com/viewarticle/585982 through http://www.medscape.com. Accessed July 2010.

(© 1995–2010). Unit Code 80309: Apolipoprotein A1, Plasma. Mayo Clinic, Mayo Medical Laboratories [On-line information]. Available online at http://www.mayomedicallaboratories.com/test-catalog/Overview/80309 through http://www.mayomedicallaboratories.com. Accessed July 2010.

Delgado, J. et. al. (Updated 2010 April). Cardiovascular Disease (Non-traditional Risk Markers) - Risk Markers - CVD (Non-traditional). ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/CVDRiskMarkerNontrad.html?client_ID=LTD# through http://www.arupconsult.com. Accessed July 2010.

O'Riordan, M. (2007 March 22). High Levels of Apolipoprotein A1 and HDL Associated With Reduced Risk of Recurrent VTE. Medscape Today [On-line information]. Available online at http://www.medscape.com/viewarticle/554016 through http://www.medscape.com. Accessed July 2010.

Myers, G. Editor (2009). Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines [On-line information]. PDF available for download at http://www.aacc.org/members/nacb/LMPG/OnlineGuide/PublishedGuidelines/risk/Documents/EmergingCV_RiskFactors09.pdf through http://www.aacc.org/members/nacb/LMPG. Accessed July 2010.

Pagana, K. D. & Pagana, T. J. (© 2007). Mosby's Diagnostic and Laboratory Test Reference 8th Edition: Mosby, Inc., Saint Louis, MO. Pp 110-114.

Wu, A. (© 2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition: Saunders Elsevier, St. Louis, MO. Pp 142-145.

Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE, eds. St. Louis: Elsevier Saunders; 2006 Pp 916-917, 928-934.